HVO Hvivo Plc

TIDMVENN

RNS Number : 4690D

Venn Life Sciences Holdings PLC

26 April 2017

26 April 2017

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Result of Annual General Meeting

Venn Life Sciences Holdings plc (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that, at the Annual General Meeting held earlier today, all resolutions proposed were duly passed.

Enquiries:

 
 Venn Life Sciences Holdings Plc       Tel: +353 1 5499341 
  Allan Wood, Non-Executive Chairman 
  Tony Richardson, Chief Executive 
  Officer 
------------------------------------  -------------------- 
 Davy (Nominated Adviser and Broker)   Tel: +353 1 679 
  Fergal Meegan / Matthew de Vere       6363 
  White (Corporate Finance) 
  Orla Bolger (Corporate Broking) 
------------------------------------  -------------------- 
 Hybridan LLP (Co-Broker)              Tel: +44 (0)20 
  Claire Louise Noyce                   3764 2341 
------------------------------------  -------------------- 
 Walbrook PR Ltd                       Tel: +44(0)20 
                                        7933 8787 
------------------------------------  -------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGUNVNRBKASUAR

(END) Dow Jones Newswires

April 26, 2017 13:01 ET (17:01 GMT)

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024